ANDA 86256, held by Taro. Hydrocortisone.
As of Nov 13, 2026, ANDA 86256 (Hydrocortisone), held by Taro, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrocortisone0.5% ยท ointment;topical | Hydrocortisone | Discontinued |
| Jul 3, 1984 | Supplement 6Manufacturing | Approved | None posted |
| May 24, 1982 | Supplement 5Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
